![](https://www.webhealthnetwork.com/img/webhealth-logo.png)
Cataplexy - 25 Studies Found
Recruiting |
: A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy : Narcolepsy With Cataplexy : 2017-01-23 :
|
Recruiting |
: Efficacy and Safety of Pitolisant in Pediatric Narcoleptic Patients With or Without Cataplexy, Double-blind Study Followed by a Prolonged Open-label Period :
|
Completed |
: Pitolisant to Assess Weekly Frequency of Cataplexy Attacks and EDS in Narcoleptic Patients (HARMONY CTP) :
: |
Completed |
: Exploratory Clinical Study to Evaluate Sodium Oxybate (Xyrem) on Potential Endocrine Changes : Narcolepsy With Cataplexy : 2006-06-28 : Drug: Sodium Oxybate (Xyrem) Active Substance: Sodium Oxybate Pharmaceutical form: Oral Solution Concent |
Active, not recruiting |
: A Multicenter Study of the Efficacy and Safety of Xyrem With an Open- Label Pharmacokinetic Evaluation and Safety Extension in Pediatric Subjects With Narcolepsy With Cataplexy : Narcolepsy With Cataplexy : 2014-07-28 : Drug: Xyrem |
Completed |
: Efficacy and Safety Study of BF2.649 and BF2.649 Add on Modafinil on Cataplexy in Patients With Narcolespy :
|
Recruiting |
: Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy :
|
Recruiting |
: Xyrem and Brain Dopamine in Narcolepsy : Narcolepsy With Cataplexy : 2015-12-17 : Drug: Xyrem single 3.0 gram dose Other Names: |
Completed |
: Single-dose Safety Study of APD916 in Healthy Volunteers : Narcolepsy With or Without Cataplexy : 2010-03-24 : Drug: APD916 |
Completed |
: Long Term Open Label Study in Narcolepsy With BF2.649 (Pitolisant) :
: 2011-06-21 : Drug: BF2.649 5,10,20,or 40 mg per day, in a once daily scheme |